Recent, as yet fragmentary evidence suggests that intervention with GLP1-RA, e.g., liraglutide, may reduce body weight and improve hyperandrogenism and menstrual irregularities in women with obesity and PCOS 28,29,30,31,32
This PWA model mimics a subtype of PCOS patients that exhibit chronic hyperandrogenism, with marked metabolic, hormonal, and reproductive/gonadal alterations, which represent the majority of cases
Therefore, through this article, we aim to provide informational awareness about GLP-1 drugs and their role in managing type 2 diabetes
And it acts on appetite centers in the brain, reducing hunger and promoting satiety
Zander, M., Madsbad, S., Madsen, J
Glucagon-like peptide-1 (GLP-1) agonists represent a class of medications that mimic the action of the naturally occurring incretin hormone GLP-1